Belluscura (BELL) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Belluscura

NOTE: This is based on 4 open tips for Belluscura (BELL)


Belluscura (BELL)
Latest Quote Price

0.75p

Belluscura (BELL)
Price Change (%)

-0.69%


Latest Bid : 0.70p Latest Ask : 0.80p
High Today : 0.92p Low Today : 0.70p
This Years High : 16.00p This Years Low : 0.55p
Volume : 2,751,008 MKT Cap : £1.26M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Belluscura (BELL) Overview

Belluscura focuses on novel oxygen-based treatment platforms that can be adapted and applied in a wide range of markets beyond those traditionally applicable to a single product or product line. Its range of portable products will be lighter / more adaptable / have higher O₂ capacity than existing oxygen enrichment products. Whilst potentially useful for recovering COVID patients, it has a wide range of use for sufferers of pneumonia / COPD (i.e. asthma/ emphysema /chronic bronchitis) and other respiratory illnesses.

Belluscura (BELL) Latest Tips

Type Tipster SectorScore Start date Performance
Sell Tom Winnifrith Premium Only 2025-04-16 08:50:00 16/04/2025 -7.14%
Sell Tom Winnifrith Premium Only 2024-01-02 08:10:00 02/01/2024 96.59%
Buy Joanne Hart Premium Only 2022-11-12 21:50:00 12/11/2022 -98.75%
Buy Stuart Blair Premium Only 2021-08-02 08:55:00 02/08/2021 -83.33%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Belluscura (BELL) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 0.70p Latest Ask : 0.80p
High Today : 0.92p Low Today : 0.70p
This Years High : 16.00p This Years Low : 0.55p
Volume : 2,751,008 MKT Cap : £1.26M

Belluscura Overview

Belluscura focuses on novel oxygen-based treatment platforms that can be adapted and applied in a wide range of markets beyond those traditionally applicable to a single product or product line. Its range of portable products will be lighter / more adaptable / have higher O₂ capacity than existing oxygen enrichment products. Whilst potentially useful for recovering COVID patients, it has a wide range of use for sufferers of pneumonia / COPD (i.e. asthma/ emphysema /chronic bronchitis) and other respiratory illnesses.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Belluscura Tips

Type Tipster SectorScore Start date Performance
Sell Tom Winnifrith Premium Only 2025-04-16 08:50:00 16/04/2025 -7.14%
Sell Tom Winnifrith Premium Only 2024-01-02 08:10:00 02/01/2024 96.59%
Buy Joanne Hart Premium Only 2022-11-12 21:50:00 12/11/2022 -98.75%
Buy Stuart Blair Premium Only 2021-08-02 08:55:00 02/08/2021 -83.33%